BioXcel Therapeutics (BTAI) EPS (Basic) (2017 - 2026)
BioXcel Therapeutics' (BTAI) quarterly EPS (Basic) came in at -$0.6 in Q1 2026, up 78.9% year-on-year from -$0.34 in Q1 2025, and up 48.74% quarter-over-quarter from -$1.18 in Q4 2025.
BioXcel Therapeutics (BTAI) EPS (Basic) (2017 - 2026) Analysis & Trends
BioXcel Therapeutics' EPS (Basic) history runs 10 years deep, the most recent figure standing at -$0.6 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 78.9% year-over-year to -$0.6 in Q1 2026; TTM through Mar 2026 was -$2.81, a 77.27% increase from a year earlier, with the FY2025 full-year figure at -$5.44, up 94.63% from the prior year.
- EPS (Basic) rose to -$0.6 in Q1 2026 per BTAI's latest filing, from -$1.18 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.6 in Q1 2026 and bottomed at -$96.97 in Q4 2022.
- The 5-year median for EPS (Basic) is -$12.12 (2023), against an average of -$21.88.
- Across the five-year window, EPS (Basic) tumbled 511.79% in 2022 and soared 87.51% in 2023, its largest moves.
- Year by year, EPS (Basic) stood at -$96.97 in 2022, then surged by 87.51% to -$12.12 in 2023, then surged by 76.42% to -$2.86 in 2024, then soared by 58.83% to -$1.18 in 2025, then jumped by 48.74% to -$0.6 in 2026.
- Per Business Quant, the three latest BTAI EPS (Basic) figures stand at -$0.6 (Q1 2026), -$1.18 (Q4 2025), and -$1.26 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 0.32 |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 1.42 |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -1.49 |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 6.32 |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 0.15 |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 1.97 |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 0.11 |
| 10 | BioXcel Therapeutics | 20.05 Mn | 20.05 Mn | -77,000.00 | -0.60 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.60 |
| Dec 31, 2025 | -1.18 |
| Sep 30, 2025 | -1.26 |
| Jun 30, 2025 | -2.53 |
| Mar 31, 2025 | -2.86 |
| Dec 31, 2024 | -2.86 |
| Sep 30, 2024 | -6.97 |
| Jun 30, 2024 | -8.08 |
| Mar 31, 2024 | -13.90 |
| Dec 31, 2023 | -12.12 |
| Sep 30, 2023 | -29.82 |
| Jun 30, 2023 | -32.90 |
| Mar 31, 2023 | -47.67 |
| Dec 31, 2022 | -96.97 |
| Sep 30, 2022 | -33.42 |
| Jun 30, 2022 | -34.16 |
| Mar 31, 2022 | -44.69 |
| Dec 31, 2021 | -15.85 |
| Sep 30, 2021 | -53.42 |
| Jun 30, 2021 | -17.70 |